Back to Menu
What is medullary thyroid carcinoma?
Medullary thyroid carcinoma originates from thyroid parafollicular cells (C cells) and is a neuroendocrine tumor. A defining feature is calcitonin secretion, leading to markedly elevated serum levels. It accounts for 1%–2% of thyroid cancers and is classified as sporadic or hereditary.
Main types and classification of medullary thyroid carcinoma
1.Sporadic medullary thyroid carcinoma
Accounts for 70%–75% of cases, with no hereditary background, typically presenting as a solitary tumor at an older age, and is associated with somatic RET mutations.
2.Hereditary medullary thyroid carcinoma
Accounts for 25%–30% of cases, inherited in an autosomal dominant manner and associated with germline RET mutations, including MEN2A, MEN2B, and familial forms.
Etiology of medullary thyroid carcinoma
1.RET mutations
The central cause. Germline RET mutations lead to hereditary disease, whereas somatic RET mutations lead to sporadic disease; mutation sites correlate with aggressiveness.
2.Hereditary syndromes
Primarily MEN2: MEN2A is associated with pheochromocytoma and other manifestations, whereas MEN2B is associated with mucosal neuromas and is the most aggressive subtype.
3.Other genetic alterations
Rarely associated with mutations in RAS, HRAS, KRAS, and related genes, more commonly observed in sporadic cases.
4.Radiation exposure
A history of head and neck radiotherapy in childhood is a risk factor, but the association with medullary thyroid carcinoma is weaker than that with papillary thyroid carcinoma.
Prevention and health maintenance for medullary thyroid carcinoma
1.Genetic screening and counseling
RET genetic testing is recommended for confirmed patients and their relatives. For carriers, the timing of prophylactic surgery should be determined based on risk stratification.
2.Regular examinations and self-checks
The general population should undergo periodic ultrasound examinations and learn neck self-examination. Individuals with a family history should adhere strictly to surveillance plans.
3.Healthy lifestyle
Maintain a balanced diet and avoid iodine excess or deficiency. Exercise regularly and avoid unnecessary head and neck radiation exposure.
4.Long-term standardized follow-up
After surgery, lifelong monitoring of serum calcitonin, CEA, and neck ultrasonography is required. Even patients with biochemical cure should continue follow-up.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that although medullary thyroid carcinoma is rare, it has strong hereditary features and a propensity for metastasis. Modern principles emphasize “gene-guided management, curative surgery, and longitudinal care.” Genetic screening enables prevention, precision surgery aims for cure, and targeted agents provide options for advanced disease. Patients and family members should actively participate in genetic counseling and systematic management to achieve optimal long-term survival.
What is medullary thyroid carcinoma?
Medullary thyroid carcinoma originates from thyroid parafollicular cells (C cells) and is a neuroendocrine tumor. A defining feature is calcitonin secretion, leading to markedly elevated serum levels. It accounts for 1%–2% of thyroid cancers and is classified as sporadic or hereditary.
Main types and classification of medullary thyroid carcinoma
1.Sporadic medullary thyroid carcinoma
Accounts for 70%–75% of cases, with no hereditary background, typically presenting as a solitary tumor at an older age, and is associated with somatic RET mutations.
2.Hereditary medullary thyroid carcinoma
Accounts for 25%–30% of cases, inherited in an autosomal dominant manner and associated with germline RET mutations, including MEN2A, MEN2B, and familial forms.
Etiology of medullary thyroid carcinoma
1.RET mutations
The central cause. Germline RET mutations lead to hereditary disease, whereas somatic RET mutations lead to sporadic disease; mutation sites correlate with aggressiveness.
2.Hereditary syndromes
Primarily MEN2: MEN2A is associated with pheochromocytoma and other manifestations, whereas MEN2B is associated with mucosal neuromas and is the most aggressive subtype.
3.Other genetic alterations
Rarely associated with mutations in RAS, HRAS, KRAS, and related genes, more commonly observed in sporadic cases.
4.Radiation exposure
A history of head and neck radiotherapy in childhood is a risk factor, but the association with medullary thyroid carcinoma is weaker than that with papillary thyroid carcinoma.
Prevention and health maintenance for medullary thyroid carcinoma
1.Genetic screening and counseling
RET genetic testing is recommended for confirmed patients and their relatives. For carriers, the timing of prophylactic surgery should be determined based on risk stratification.
2.Regular examinations and self-checks
The general population should undergo periodic ultrasound examinations and learn neck self-examination. Individuals with a family history should adhere strictly to surveillance plans.
3.Healthy lifestyle
Maintain a balanced diet and avoid iodine excess or deficiency. Exercise regularly and avoid unnecessary head and neck radiation exposure.
4.Long-term standardized follow-up
After surgery, lifelong monitoring of serum calcitonin, CEA, and neck ultrasonography is required. Even patients with biochemical cure should continue follow-up.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that although medullary thyroid carcinoma is rare, it has strong hereditary features and a propensity for metastasis. Modern principles emphasize “gene-guided management, curative surgery, and longitudinal care.” Genetic screening enables prevention, precision surgery aims for cure, and targeted agents provide options for advanced disease. Patients and family members should actively participate in genetic counseling and systematic management to achieve optimal long-term survival.